195 related articles for article (PubMed ID: 38177532)
1. Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth.
Bodac A; Mayet A; Rana S; Pascual J; Bowler AD; Roh V; Fournier N; Craciun L; Demetter P; Radtke F; Meylan E
EMBO Mol Med; 2024 Jan; 16(1):158-184. PubMed ID: 38177532
[TBL] [Abstract][Full Text] [Related]
2. Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-β (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation.
Gautam S; Kirschnek S; Gentle IE; Kopiniok C; Henneke P; Häcker H; Malleret L; Belaaouaj A; Häcker G
Cell Death Differ; 2013 Aug; 20(8):1068-79. PubMed ID: 23686134
[TBL] [Abstract][Full Text] [Related]
3. BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropenia.
Carrington EM; Louis C; Kratina T; Hancock M; Keenan CR; Iannarella N; Allan RS; Wardak AZ; Czabotar PE; Herold MJ; Schenk RL; White CA; D'Silva D; Yang Y; Wong W; Wong H; Bryant VL; Huntington ND; Rautela J; Sutherland RM; Zhan Y; Hansen J; Nhu D; Lessene G; Wicks IP; Lew AM
Blood Adv; 2021 Jun; 5(11):2550-2562. PubMed ID: 34100903
[TBL] [Abstract][Full Text] [Related]
4. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung.
Qian J; Zou Y; Rahman JS; Lu B; Massion PP
Mol Cancer Ther; 2009 Jan; 8(1):101-9. PubMed ID: 19139118
[TBL] [Abstract][Full Text] [Related]
5. Delayed apoptosis by neutrophils from COPD patients is associated with altered Bak, Bcl-xl, and Mcl-1 mRNA expression.
Zhang J; He J; Xia J; Chen Z; Chen X
Diagn Pathol; 2012 Jun; 7():65. PubMed ID: 22686245
[TBL] [Abstract][Full Text] [Related]
6. The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.
Cao X; Yap JL; Newell-Rogers MK; Peddaboina C; Jiang W; Papaconstantinou HT; Jupitor D; Rai A; Jung KY; Tubin RP; Yu W; Vanommeslaeghe K; Wilder PT; MacKerell AD; Fletcher S; Smythe RW
Mol Cancer; 2013 May; 12(1):42. PubMed ID: 23680104
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition.
Weeden CE; Ah-Cann C; Holik AZ; Pasquet J; Garnier JM; Merino D; Lessene G; Asselin-Labat ML
Oncogene; 2018 Aug; 37(32):4475-4488. PubMed ID: 29743589
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs.
Diepstraten ST; Young S; La Marca JE; Wang Z; Kluck RM; Strasser A; Kelly GL
Cell Death Differ; 2023 Apr; 30(4):1005-1017. PubMed ID: 36755070
[TBL] [Abstract][Full Text] [Related]
9. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.
Aprikyan AA; Liles WC; Park JR; Jonas M; Chi EY; Dale DC
Blood; 2000 Jan; 95(1):320-7. PubMed ID: 10607719
[TBL] [Abstract][Full Text] [Related]
10. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
Meng Y; Tang W; Dai Y; Wu X; Liu M; Ji Q; Ji M; Pienta K; Lawrence T; Xu L
Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
[TBL] [Abstract][Full Text] [Related]
11. Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.
Othman N; In LL; Harikrishna JA; Hasima N
PLoS One; 2013; 8(12):e81735. PubMed ID: 24339958
[TBL] [Abstract][Full Text] [Related]
12. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.
Bai L; Chen J; McEachern D; Liu L; Zhou H; Aguilar A; Wang S
PLoS One; 2014; 9(6):e99404. PubMed ID: 24901320
[TBL] [Abstract][Full Text] [Related]
13. The BH3-only proteins BIM and PUMA are not critical for the reticulocyte apoptosis caused by loss of the pro-survival protein BCL-XL.
Delbridge AR; Aubrey BJ; Hyland C; Bernardini JP; Di Rago L; Garnier JM; Lessene G; Strasser A; Alexander WS; Grabow S
Cell Death Dis; 2017 Jul; 8(7):e2914. PubMed ID: 28682312
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
[TBL] [Abstract][Full Text] [Related]
15. Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.
Pécot J; Maillet L; Le Pen J; Vuillier C; Trécesson SC; Fétiveau A; Sarosiek KA; Bock FJ; Braun F; Letai A; Tait SWG; Gautier F; Juin PP
Cell Rep; 2016 Dec; 17(12):3347-3358. PubMed ID: 28009301
[TBL] [Abstract][Full Text] [Related]
16. Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
Inoue-Yamauchi A; Jeng PS; Kim K; Chen HC; Han S; Ganesan YT; Ishizawa K; Jebiwott S; Dong Y; Pietanza MC; Hellmann MD; Kris MG; Hsieh JJ; Cheng EH
Nat Commun; 2017 Jul; 8():16078. PubMed ID: 28714472
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated V-ATPase induces delayed apoptosis of protumorigenic neutrophils.
Ibrahim SA; Kulshrestha A; Katara GK; Riehl V; Sahoo M; Beaman KD
Mol Oncol; 2020 Mar; 14(3):590-610. PubMed ID: 31925882
[TBL] [Abstract][Full Text] [Related]
18. Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells.
Santos-Beneit AM; Mollinedo F
J Leukoc Biol; 2000 May; 67(5):712-24. PubMed ID: 10811013
[TBL] [Abstract][Full Text] [Related]
19. Induction of Bim limits cytokine-mediated prolonged survival of neutrophils.
Andina N; Conus S; Schneider EM; Fey MF; Simon HU
Cell Death Differ; 2009 Sep; 16(9):1248-55. PubMed ID: 19407828
[TBL] [Abstract][Full Text] [Related]
20. The identification of BCL-XL and MCL-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance.
Fitzgerald MC; O'Halloran PJ; Kerrane SA; Ní Chonghaile T; Connolly NMC; Murphy BM
Cell Death Dis; 2023 Oct; 14(10):705. PubMed ID: 37898609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
